Status:
COMPLETED
Neonatal Cardio-Pulmonary Outcome Measure
Lead Sponsor:
Asir John Samuel
Conditions:
Congenital Heart Defect
Respiratory Distress Syndrome in Premature Infant
Eligibility:
All Genders
28-1 years
Brief Summary
Neonatal Cardio-Pulmonary outcome measure (N-COM) will be used to assess the overall status of pulmonary and cardiac vascular system of neonates in Neonatal Intensive Care Unit (NICU). There are many ...
Detailed Description
Background: Neonatal Intensive care unit (NICU) is exclusively created to treat premature and fragile neonates. The neonates with intrauterine growth limitations with congenital heart defects and res...
Eligibility Criteria
Inclusion
- Preterm and full term neonates with cardio-pulmonary conditions Stable Neonates
Exclusion
- Neonates with severe disability Parents who are not wiling to participate their newborn in study
Key Trial Info
Start Date :
August 31 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04324957
Start Date
August 31 2020
End Date
March 31 2021
Last Update
April 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maharishi Markandeshwar (M.M) Hospital, Mullana, Ambala, Haryana
Mullana, Haryana, India, 133207